Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Assertio_Holdings
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
oncology
|
| gptkbp:founded |
1987
|
| gptkbp:founder |
gptkb:Rajesh_C._Shrotriya
|
| gptkbp:headquarters_location |
gptkb:Boston,_Massachusetts,_United_States
|
| gptkbp:headquartersLocation |
gptkb:Henderson,_Nevada,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Spectrum Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:notableProduct |
gptkb:Beleodaq
gptkb:Evomela gptkb:Fusilev gptkb:Rolontis gptkb:Marqibo |
| gptkbp:numberOfEmployees |
approximately 150 (2022)
|
| gptkbp:status |
defunct
|
| gptkbp:tradedOn |
gptkb:NASDAQ:_SPPI
|
| gptkbp:website |
https://www.sppirx.com/
|
| gptkbp:bfsParent |
gptkb:Talon_Therapeutics
|
| gptkbp:bfsLayer |
6
|